LY293111

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY293111, covering 2007-01-26 to 2007-12-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer [Phase 2]